Searched for
ANTI OBESITY MEDICINE
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weig...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Ahead of its time, a GLP-1 drug almost made it out of IndiaFifteen years back, Zydus Lifesciences introduced ZYOG1, an oral GLP-1 agonist that sparked excitement for its implications in diabetes man...
- Novo Nordisk cuts price for Ozempic, Wegovy. How much weight-loss, anti-obesity, diabetes medicines will cost?Wegovy and Ozempic price cuts will be effective January 1 next year, coinciding with the implementation of new, lower prices for the same ...
- Future diabetes care seen leaning towards GLP-1 drugsThe diabetes treatment landscape in India is on the brink of transformation. Innovative GLP-1 medications are set to redefine therapy stand...
- HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
- Obesity drug Mounjaro becomes India's top-selling drug by value in OctoberEli Lilly's Mounjaro drug has become India's top seller for October as sales reached one billion rupees. This anti-obesity medication helps...
- Eli Lilly to invest $1 billion in India, expand manufacturing and introduce oral weight-loss drugEli Lilly is significantly expanding its Indian operations with over $1 billion in contract manufacturing investments and plans for a globa...
- Novo Nordisk’s Wegovy enters India: Can this weight loss jab beat Mounjaro? Price, who can use it & how it worksNovo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy conta...
- You can get a shot for speedy weight loss at Rs 14k a monthThe 2.5 mg vial and 5 mg vial will be available at Rs 3,500 and Rs 4,375, respectively. A spokesperson said as Mounjaro (tirzepatide) is a ...
- ‘Obese people should opt for a structured programme of diet, exercise & medication’"Nothing comes without a downside. These molecules do produce significant nausea and vomiting in some people — to the extent that they have...
- Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivotWeight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in gen...
- Demand for weight-loss drugs fuels global rise in counterfeitsThe increasing demand for weight-loss drugs such as Novo Nordisk's Ozempic has led to a rise in counterfeit versions of these medications. ...
- Hyderabad's pictureque Durgam Cheruvu lake water has antidepressants, painkillers, sewage and even cocaineResearchers have found a cocktail of pollutants in Hyderabad's Durgam Cheruvu lake. In addition to pollutants such as cyanotoxins, pesticid...
- Five diabetes drugs in top-10 selling list; overtakes anti-infective, antibiotic medsInsulin brand Human Mixtard, oral formulation Glycomet GP, insulin Lantus, oral formulations Galvus Met and Janumet are now in the top-sell...
- Centre bans anti-obesity drug due to side effectsThe government has banned manufacturing and sale of anti-obesity medicine Sibutramine and its combination drugs sold under various brands d...
Load More
